ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 176 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $17,987,000 | +56.2% | 1,667,000 | 0.0% | 0.73% | +63.5% |
| Q3 2015 | $11,519,000 | -58.4% | 1,667,000 | -40.7% | 0.45% | -50.3% |
| Q1 2015 | $27,708,000 | -22.5% | 2,810,164 | -3.8% | 0.90% | -30.2% |
| Q4 2014 | $35,774,000 | +37556.8% | 2,920,300 | +23262.4% | 1.28% | +32025.0% |
| Q2 2014 | $95,000 | -68.9% | 12,500 | -86.5% | 0.00% | -66.7% |
| Q1 2014 | $305,000 | -97.7% | 92,804 | -94.3% | 0.01% | -98.1% |
| Q2 2013 | $13,332,000 | – | 1,629,833 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |